{"doi":"10.1101/2020.07.23.20161000","title":"Time to SARS-CoV-2 Clearance Among Patients with Cancer and COVID-19","abstract":"QUESTION: What is the median time to clearance of SARS-CoV-2 among cancer patients according to currently used criteria? FINDINGS: In this single-institution retrospective cohort study, the median time to SARS-CoV-2 clearance was 50 days using the ASCO/CDC criteria of 2 negative RT-PCR assays >24 hours apart. Using alternative criteria of 1 negative RT-PCR assay (UK-NICE) or CDC clinical criteria (10 days after first positive RT-PCR and 3 days after last symptoms), median clearance times were 31 days and 13 days, respectively. Meaning: SARS-CoV-2 clearance times differ substantially depending on criteria used and may be prolonged in cancer patients.","journal":"medRxiv","year":2020,"id":121679,"datarank":0.0,"base_score":0.0,"endowment":0.0,"self_citation_contribution":0.0,"citation_network_contribution":0.0,"self_endowment_contribution":0.0,"citer_contribution":0.0,"corpus_percentile":null,"corpus_rank":null,"citation_count":6,"citer_count":0,"citers_with_citation_signal":0,"citers_with_endowment":0,"datacite_reuse_total":0,"is_dataset":false,"is_dataset_confidence":0.9536,"is_data_producer":false,"deposit_databanks":null,"is_oa":true,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":"2020-01-01","fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":561692,"name":"Andrew J. Piper-Valillo","orcid":"0000-0003-0742-0350","position":1,"is_corresponding":false},{"id":482273,"name":"Poorva Bindal","orcid":"0000-0002-3186-0113","position":2,"is_corresponding":false},{"id":562421,"name":"Jonathan W. Wischhusen","orcid":null,"position":3,"is_corresponding":false},{"id":335439,"name":"Jaymin Patel","orcid":null,"position":4,"is_corresponding":false},{"id":297163,"name":"Daniel B. Costa","orcid":"0000-0002-0689-395X","position":5,"is_corresponding":false},{"id":561693,"name":"Mary Linton B. Peters","orcid":"0000-0003-0905-7583","position":6,"is_corresponding":false},{"id":437387,"name":"Wenxin Xu","orcid":"0000-0002-8450-2037","position":0,"is_corresponding":true}],"reference_count":5,"raw_metadata":null,"created_at":"2026-07-18T23:14:46.979435Z","pmid":"32743607","pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}